Abstract:Background Transplantation of adult bone marrow-derived mesenchymal stem cells (MSCs) has been proposed as a strategy for cardiac repair following myocardial damage. However cell transplantation strategies to replace lost myocardium are limited by the inability to deliver large numbers of cells that resist peritransplantation graft cell death. Accordingly, we set out to isolate and expand adult swine bone marrow-derived MSCs, and to engineer these cells to overexpress AKT1 (protein kinase B), to test the hypothesis that AKT1-engineered MSCs are more resistant to apoptosis and can enhance cardiac repair after transplantation into the ischemic swine heart. Methods The CDS (regulation domain of AKT1) AKT1-cDNA fragment was amplified, and MSCs were transfected following synthesis with a pCDH1-AKT1 shuttling plasmid. Western blotting analysis and real-time reverse transcription-polymerase chain reaction (RT-PCR) was performed. Myocardial infarction (MI) models were constructed in Meishan pigs, and cardiac function was evaluated by magnetic resonance imaging (MRI) measurements and echocardiography 4 weeks later. All pigs were assigned to four groups: control (A), DMEM (B), MSC (C), and AKT-transfected (D). MSCs were transfected with the AKT1 gene, and autologous BrdU-labeled stem cells (1 × 107/5 ml) were injected into left anterior descending coronary atery (LAD) of the infarct heart in groups C and D. In group B, DMEM was injected using the same approach. In group A, there was no injection following LAD occlusion. After 4 weeks, cardiac function and regional perfusion measurements were repeated by MRI and echocardiography, and histological characteristics of the hearts were assessed. Connecxin-43 (CX-43), BrdU, and von Willebrand factor (VWF) immunoreactivity was tested using enzyme linked immunosorbent assay (ELISA). Vascular endothelial growth factor (VEGF), transforming growth factor-β1 (TGF-β1) were analyzed at the same time. Results AKT1-cDNA was cloned into pCDH1-MCS1-EF1-copGFP and the sequence was confirmed. AKT mRNA expression was detected at 24 hours after transfection. AKT1 expression in MSCs remained strong after 2 weeks, according to real-time RT-PCR and Western blotting. Prior to cell implantation, end-diastolic left ventricular dimension (EDLVd) increased and stroke volume (SV) decreased in the MI hearts. MRI scans revealed significantly improved cardiac function following implantation, and implanted MSCs prevented thinning and expanding in the infarct region, as well as improved contraction and increased perfusion in all groups compared to control hearts. The left ventricular chamber size was smaller in cell-transplanted hearts than in control hearts. Moreover, group D exhibited significant improvement. The expression of CX-43, BrdU, and VWF could be found in the immunohistochemical pathological sections of group C and group D. The level of VEGF reached a high level 1 week after implanting the MSCs, but the level of TGF-β1 decreased gradually. Conclusions The AKT1-expressing lentiviral vector resulted in stable over-expression of AKT1 in MSCs. MSC engraftment in host myocardium improved cardiac function by attenuating contractile dysfunction and pathological thinning of the infracted left ventricular wall, which likely resulted from myocardial regeneration and angiogenesis.

Development and characterization of Gal KO porcine bone marrow-derived mesenchymal stem cells

Galactosyl-knock-out engineered pig as a xenogenic donor source of adipose MSCs for bone regeneration

Therapeutic Angiogenesis of Bone Marrow Mononuclear Cells (mncs) and Peripheral Blood Mncs: Transplantation for Ischemic Hindlimb

Development and characterization of novel clinical grade neonatal porcine bone marrow-derived mesenchymal stem cells

Development and characterization of islet-derived mesenchymal stem cells from clinical grade neonatal porcine cryopreserved islets

The potential role of genetically-modified pig mesenchymal stromal cells in xenotransplantation

Characteristics and neural-like differentiation of mesenchymal stem cells derived from foetal porcine bone marrow.

Transplantation Routes and Mechanism of Mesenchymal Stem Cell Therapy in Porcine Models with Acute Liver Failure

High incidence of xenogenic bone marrow engraftment in pig-to-baboon intra-bone bone marrow transplantation

Research Advancements in Porcine Derived Mesenchymal Stem Cells

Experiment of Autologus Bone Marrow Mesenchymal Stem Cell Transplantation for Pigs with Acute Myocardial Infarction

PERIPHERAL BLOOD DERIVED MESENCHYNAL STEM CELLS IN THE GFP RATS

Treatment of acute hog myocardial infarction by autologous bone marrow mesenchymal stem cells

Mesenchymal Stem Cells Genetically Modified with the Angiopoietin-1 Gene Enhanced Arteriogenesis in a Porcine Model of Chronic Myocardial Ischaemia.

Xenotransplantation of neonatal porcine bone marrow-derived mesenchymal stem cells improves diabetic wound healing by promoting angiogenesis and lymphangiogenesis

Proteomic Analysis of Porcine Mesenchymal Stem Cells Derived from Bone Marrow and Umbilical Cord: Implication of the Proteins Involved in the Higher Migration Capability of Bone Marrow Mesenchymal Stem Cells

The Effectiveness of Allogeneic Mesenchymal Stem Cells Therapy for Knee Osteoarthritis in Pigs

Repair of bone defects in rhesus monkeys with α1,3-galactosyltransferase-knockout pig cancellous bone

Xenotransplantation of long-term-cultured swine bone marrow-derived mesenchymal stem cells

Alpha1,3-galactosyltransferase Knockout Does Not Alter the Properties of Porcine Extracellular Matrix Bioscaffolds

AKT-modified Autologous Intracoronary Mesenchymal Stem Cells Prevent Remodeling and Repair in Swine Infarcted Myocardium.